Update Reimbursement Fludrace®
The existing TBR for Fludrace® 62.50 micrograms has been expanded with the strength 31.25 micrograms. Because the health insurer...
Reimbursement Scheme Acecort®
The health insurer fully reimburses Acecort® 1, 2 and 3 mg as off March 1, 2023. The reimbursement by TBR Nederland will therefore...
Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg for the treatment of HFpEF (LVEF >40%)
The health insurer does not yet fully reimburse Forxiga® (dapagliflozin) 10 mg for the treatment of HFpEF (LVEF >40%). The...
Reimbursement Scheme Isturisa®
The health insurer does not fully reimburse Isturisa® 1mg, 5mg and 10mg. The producer of this medicine has therefore asked TBR...
Termination TerugBetaalRegeling Forxiga® - Chronic Kidney Disease
From May 1st 2022 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of chronic kidney disease (CKD) is fully reimbursed...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine